Search results

• Atropine
  ...arinic acetylcholine receptor]]. It is classified as an [[anticholinergic drug]]. Being potentially deadly, it derives its name from [[Atropos]], one of t ...(a shorter-acting [[cholinergic]] antagonist) or [[phenylephrine]] (an α-adrenergic agonist) is preferred as an aid to [[ophthalmic]] examination. Atropine ind
  16 KB (2,198 words) - 16:46, 27 September 2010
• User:Nayrouz Aly/Atropine
  ...arinic acetylcholine receptor]]. It is classified as an [[anticholinergic drug]]. Being potentially deadly, it derives its name from [[Atropos]], one of t ...(a shorter-acting [[cholinergic]] antagonist) or [[phenylephrine]] (an α-adrenergic agonist) is preferred as an aid to [[ophthalmic]] examination. Atropine ind
  15 KB (1,975 words) - 15:07, 6 July 2010
• Methyldopa
  | pregnancy_category = a drug of choice in [[Pregnancy-induced hypertension|PIH]] ...'', '''Aldoril''', '''Dopamet''', '''Dopegyt''', etc.) is a [[psychoactive drug]] used as a [[sympatholytic]] or [[antihypertensive]]. Its use is now depre
  8 KB (905 words) - 10:56, 20 September 2010
• Dopamine
  ...use dopamine cannot cross the [[blood-brain barrier]], dopamine given as a drug does not directly affect the [[central nervous system]]. To increase the am ...ophrenia, autism, and attention deficit hyperactivity disorder, as well as drug abuse.
  48 KB (6,470 words) - 16:48, 27 September 2010
• Salbutamol
  ...AN]]) is a short-acting [[beta2-adrenergic receptor agonist|β₂-adrenergic receptor agonist]] used for the relief of [[bronchospasm]] in conditions su .... It was first sold by Allen & Hanburys under the brand name Ventolin. The drug was an instant success, and has been used for the treatment of asthma ever
  15 KB (2,005 words) - 16:49, 27 September 2010
• Epinephrine
  |metabolism = [[synapse|adrenergic synapse]] ([[Monoamine oxidase|MAO]] and [[Catechol-O-methyl transferase|CO {{See also|Adrenergic receptor}}
  22 KB (2,916 words) - 16:50, 27 September 2010
• Nitrous oxide
  ...ic]] effects of inhaling it, a property that has led to its [[recreational drug use|recreational use]] as a [[dissociative]] [[anesthetic]]. It is also use ...ung diseases could be treated by inhalation of "Factitious Airs"<ref name="Drug discovery"/> (the word [[factitious]] means "artificial").
  61 KB (8,728 words) - 16:50, 27 September 2010
• Ephedrine
  ...e book | editor= Edited by Reynolds JEF | title=[[Martindale: The complete drug reference]] | edition=29th | date=1989 | publisher=Pharmaceutical Press | l ...macological Effects of Ephedrine Alkaloids on Human {alpha}1- and {alpha}2-Adrenergic Receptor Subtypes''] J. Pharmacol. Exp. Ther.; '''nr. 322''' pp. 214-221 (j
  21 KB (2,906 words) - 16:51, 27 September 2010
• Template:Hypnotics and sedatives
  | group2 = [[Alpha-2 adrenergic receptor|Alpha-2 adrenergic<br>receptor]] | group1 = [[Alpha-adrenergic agonist]]s
  7 KB (590 words) - 21:04, 24 September 2010
• Template:Antidepressants
  ...oup4 = <small>[[Beta-3 adrenergic receptor|β₃-Adrenoceptor]] [[Adrenergic agonist|agonist]]s [[Category:Drug templates|{{PAGENAME}}]]
  13 KB (1,038 words) - 16:53, 27 September 2010
• Template:Antimigraine preparations
  ...medroxone]])&nbsp;• ''[[monosaccharide]]'' ([[topiramate]])&nbsp;• ''[[adrenergic agonist]]'' ([[Clonidine]])&nbsp;• ''[[tricyclic antidepressant]]'' ([[am [[Category:Drug templates|{{PAGENAME}}]]
  2 KB (183 words) - 16:42, 19 September 2010
• Template:Cardiac stimulants excluding cardiac glycosides
  | group1 = [[epinephrine|Adrenergic]] and<BR>[[dopaminergic]] agents | group1 = [[Adrenergic agonist]]s
  2 KB (128 words) - 20:09, 21 September 2010
• Template:Drugs for obstructive airway diseases
  | group1 = [[adrenergic drug|Adrenergic]]s, [[inhalant]]s | group1 = [[beta2-adrenergic agonist|Short acting &beta;₂-agonists]]
  2 KB (191 words) - 12:10, 19 September 2010
• Template:Radiopharmaceuticals
  | group2 = [[Adrenergic]] tumors [[Category:Drug templates|{{PAGENAME}}]]
  2 KB (199 words) - 12:10, 19 September 2010
• Template:Sympatholytic antihypertensives
  ...[Sympatholytic]]s<BR>(antagonize [[Adrenergic_receptor#.CE.B1_receptors|α-adrenergic]]<BR>[[vasoconstriction]]) | group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α₂ agonist]]
  2 KB (200 words) - 12:10, 19 September 2010
• Template:Neuromodulation
  | group1 = [[Adrenergic]] ...Alpha-1 blocker|1]], [[Alpha-2 blocker|2]]), [[Beta blocker|β]]){{•}} [[Adrenergic reuptake inhibitor]] (ARI)
  4 KB (375 words) - 12:11, 19 September 2010
• Template:Adrenergics
  | title = [[Adrenergic]]s | group1 = [[Adrenergic receptor|Receptor]] [[ligand]]s
  19 KB (1,075 words) - 16:53, 27 September 2010
• Template:Antiaddictives
  ...epinephrine-dopamine reuptake inhibitor|NDRI]]'' ([[Bupropion]]){{·}} ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]){{·}} ''[[Cannabinoid receptor type 1|CB1]]' ...gonists]]'' ([[Naltrexone]], [[Nalmefene]]){{·}} [[Topiramate]]{{·}} ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]){{·}} [[Baclofen]]
  3 KB (233 words) - 12:11, 19 September 2010
• Template:Labor repressants
  | group1 = [[beta2-adrenergic receptor agonist|β₂-agonists]] | group3 = [[Non-steroidal anti-inflammatory drug|NSAID]]
  763 bytes (74 words) - 12:11, 19 September 2010
• Template:Aphrodisiacs
  | group1 = [[Adrenergic]]s ...yrate|GHB]] • [[Oxytocin]] • [[Tetrahydrocannabinol|THC]] ([[Cannabis (drug)|''Cannabis'']]) • [[UK-414,495]] • [[Vasopressin]]
  1 KB (102 words) - 17:12, 19 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)